Zealand Pharma A/S American Depositary Shares
ZEAL
ZEAL was delisted on the 29th of September, 2022.
19 hedge funds and large institutions have $81.3M invested in Zealand Pharma A/S American Depositary Shares in 2020 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 5 increasing their positions, 4 reducing their positions, and 2 closing their positions.
100% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 2
25% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 4
12% more funds holding
Funds holding: 17 → 19 (+2)
9% less capital invested
Capital invested by funds: $88.8M → $81.3M (-$7.56M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
OMC
Old Mission Capital
Chicago,
Illinois
|
+$212K |
| 2 |
Jane Street
New York
|
+$105K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$40.2K |
| 4 |
Morgan Stanley
New York
|
+$22K |
| 5 |
US Bancorp
Minneapolis,
Minnesota
|
+$8.26K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FCM
Farallon Capital Management
San Francisco,
California
|
-$9.05M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
-$1.46M |
| 3 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
-$892K |
| 4 |
Rockefeller Capital Management
New York
|
-$30.4K |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$15K |
ZEAL Hedge Fund Activity: Q1 2020 in Review
19 of the 4,547 institutional investors tracked by Wall St. Rank reported a position in Zealand Pharma A/S American Depositary Shares (ZEAL) for Q1 2020, worth a combined $81.3M — down 8.5% from $88.8M a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new ZEAL positions and 2 closed out — a net gain of 2 holders — while 5 added to existing stakes and 4 trimmed.
The largest buyer was Old Mission Capital, adding an estimated $212K. The largest seller was Farallon Capital Management, cutting an estimated $9.05M.
- 19 institutional investors held Zealand Pharma A/S American Depositary Shares (ZEAL) as of Q1 2020, up from 17 in Q4 2019.
- Funds reported $81.3M of Zealand Pharma A/S American Depositary Shares stock for Q1 2020, down 8.5% quarter-over-quarter.
- 4 funds opened new Zealand Pharma A/S American Depositary Shares positions in Q1 2020 and 2 closed out, a net change of +2 holders.
- The largest Zealand Pharma A/S American Depositary Shares buyer in Q1 2020 was Old Mission Capital, an estimated $212K added.
- The largest Zealand Pharma A/S American Depositary Shares seller in Q1 2020 was Farallon Capital Management, an estimated $9.05M sold.
Based on aggregated 13F filings for Q1 2020.